Revenue Breakdown
Composition ()
No data
Revenue Streams
Procept Biorobotics Corp (PRCT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Hand pieces and other consumables, accounting for 59.7% of total sales, equivalent to $49.73M. Other significant revenue streams include System sales and rentals and Service. Understanding this composition is critical for investors evaluating how PRCT navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Procept Biorobotics Corp maintains a gross margin of 64.81%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -27.83%, while the net margin is -25.70%. These profitability ratios, combined with a Return on Equity (ROE) of -27.22%, provide a clear picture of how effectively PRCT converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, PRCT competes directly with industry leaders such as AXGN and NVCR. With a market capitalization of $1.61B, it holds a significant position in the sector. When comparing efficiency, PRCT's gross margin of 64.81% stands against AXGN's 76.55% and NVCR's 73.25%. Such benchmarking helps identify whether Procept Biorobotics Corp is trading at a premium or discount relative to its financial performance.
